MAKO Surgical Corp. (NASDAQ:MAKO)

CAPS Rating: 5 out of 5

Mako makes a robotic surgical system for knee and hip arthoplasty procedures.

Results 1 - 20 of 161 : 1 2 3 4 5 6 7 8 9 Next »

Recs

0
Member Avatar TheCabbageMan (77.72) Submitted: 5/24/2013 7:34:08 PM : Outperform Start Price: $42.15 MAKO Score: -90.92

Wow, I think I picked MAKO on THE worst day.

Recs

0
Member Avatar Skylar0614 (71.35) Submitted: 5/22/2013 11:38:01 AM : Outperform Start Price: $11.65 MAKO Score: -1.87

Look out! This one is looking good!

Recs

1
Member Avatar Flygal5 (90.57) Submitted: 5/13/2013 1:49:28 PM : Outperform Start Price: $12.33 MAKO Score: -10.15

Aging baby boomers needing new knees, faster recoveries matter

Recs

0
Member Avatar hiddenflem (77.46) Submitted: 4/16/2013 9:00:47 PM : Outperform Start Price: $11.03 MAKO Score: -4.05

back in

Recs

2
Member Avatar buynholdisdead (56.44) Submitted: 3/31/2013 2:20:29 PM : Outperform Start Price: $11.15 MAKO Score: -4.94

I believe Minimal invasive surgery will only become bigger and bigger. In the future, when the younger doctors grow with this technology it will only become more pervasive.

Recs

1
Member Avatar IfHeDiesHeDies (43.73) Submitted: 3/30/2013 12:19:54 AM : Outperform Start Price: $11.15 MAKO Score: -4.94

Bottomed out.Increasing Revenues.Massive growth potential.Not many competitors.

Recs

0
Member Avatar NoblyNaive (84.82) Submitted: 3/11/2013 8:48:44 PM : Outperform Start Price: $13.22 MAKO Score: -21.15

Well equipped to compete in a growing market (joint replacement robots) with a high barrier to entry. Main competitor is having legal problems surrounding product performance. Despite MAKO's own problems meeting shareholder expectations, revenue is increasing.

Technical: Stock was battered down to below 1/4 of its 52-week high. Has formed a triangle, with low volume on last sell off. Not a classic head and shoulders pattern; but higher lows indicate a bottom has been reached. Renko chart confirms change in trend direction.

Recs

0
Member Avatar mrpraxis (< 20) Submitted: 3/11/2013 2:58:29 AM : Underperform Start Price: $13.07 MAKO Score: +20.60

No. The ACA tax on medical devices is going to either make this company a buyout for Intuitive Surgical or they will simply go out of business under the weight of government regulation now that Obama has got 4 more years to ruin the economy further.

Recs

1
Member Avatar JackDanny (77.22) Submitted: 3/8/2013 3:43:54 AM : Outperform Start Price: $12.55 MAKO Score: -16.93

The machines are working and in use. Though the projected sales are not as high as they could be, they're still going strong, which means they're not as bad as one orthopedic surgeon top bear seems to think.

Recs

3
Member Avatar FoolishErik (66.00) Submitted: 2/8/2013 9:51:46 PM : Outperform Start Price: $11.10 MAKO Score: -7.86

MAKO is successfully crossing the technological chasm. Sales of surgical robots have rebounded as they bring onboard more "early majority" customers, and procedure rates per installed robot remain steady indicating continued strong use by both current and new surgeons.

Recs

1
Member Avatar Charlotte49er (81.68) Submitted: 2/8/2013 9:37:13 AM : Outperform Start Price: $11.18 MAKO Score: -8.63

Crazy cheap right now.

Recs

0
Member Avatar chris293 (40.22) Submitted: 2/7/2013 12:32:14 PM : Outperform Start Price: $11.17 MAKO Score: -9.46

New medical instruments companies always have ups and downs, but the thing to watch is that the first loss earnings are being reduced on a steady basis as the company heads for profitability. Mako does so.

Recs

0
Member Avatar inyouraeroplane (< 20) Submitted: 1/26/2013 11:45:06 PM : Outperform Start Price: $12.15 MAKO Score: -17.65

I'm going with the crowd.

Recs

0
Member Avatar brandonschklar (32.87) Submitted: 1/23/2013 10:05:08 PM : Outperform Start Price: $11.96 MAKO Score: -17.02

A lot of money

Recs

4
Member Avatar SmartAce (99.71) Submitted: 1/16/2013 2:50:22 PM : Outperform Start Price: $11.65 MAKO Score: -50.26

Anyone else thinking about the sharks with laser beams here?

Recs

0
Member Avatar waugusti2 (< 20) Submitted: 1/7/2013 10:23:51 AM : Underperform Start Price: $11.35 MAKO Score: +14.49

the growth story of mako is over. q4/2012 declines from q4/2011

Recs

1
Member Avatar PETPOE (< 20) Submitted: 1/6/2013 4:58:10 AM : Outperform Start Price: $11.93 MAKO Score: -19.29

probably not an ISRG but still a great opportunity cinsidering its beaten-down prize and the potential for growth for robotic knee and hip surgeries.

Recs

0
Member Avatar StarWitchDoctor (98.32) Submitted: 12/11/2012 10:16:06 AM : Outperform Start Price: $16.50 MAKO Score: -48.74

glad i did not buy this one in real life.

Recs

0
Member Avatar bcellars (34.97) Submitted: 12/3/2012 8:25:41 AM : Outperform Start Price: $13.91 MAKO Score: -35.10

It's been beaten down and has held this level for a while. If it pops, it will go fast so best to be in already. Limited downside with lots of potential upside.

Recs

0
Member Avatar HighestVantage (74.75) Submitted: 11/11/2012 3:49:20 PM : Outperform Start Price: $14.39 MAKO Score: -41.31

Revolutionizing the way certain key surgeries are done. At bottom of a 52-week high, I think it will outperform from this price point in the short term and outperform in long term as well.

Featured Broker Partners


Advertisement